Table 2.
Parameters | Group | |||
---|---|---|---|---|
3–4 weeks | 9–10 weeks | |||
Normal diet | CDHFD | Normal diet | CDHFD | |
Steatosis score | 0.0 ± 0.0 | 3.0 ± 0.0 ** | 0.0 ± 0.0 | 3.0 ± 0.0 ** |
Inflammation score | 0.0 ± 0.0 | 1.4 ± 0.55 ** | 0.20 ± 0.45 | 2.6 ± 0.55 **, †† |
Ballooning score | 0.0 ± 0.0 | 0.20 ± 0.45 | 0.0 ± 0.0 | 1.0 ± 0.0 **, † |
NAFLD activity score | 0.0 ± 0.0 | 4.6 ± 0.89 ** | 0.20 ± 0.45 | 6.6 ± 0.55 **, †† |
Fibrosis area (%) | 1.0 ± 0.0 | 1.4 ± 0.5 | 1.0 ± 0.0 | 19.8 ± 10 *, † |
Values are expressed as means ± SDs (n = 5). *P < 0.05, **P < 0.01, compared with the respective normal diet-fed groups; †P < 0.05; ††P < 0.01, compared with the 3–4-week CDHFD-fed group
H&E haematoxylin and eosin, SR Sirius red, CDHFD choline-deficient, low-methionine high-fat diet, NAFLD non-alcoholic fatty liver disease